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Erythropoiesis follows a stepwise differentiation 
process that involves the commitment of hema-
topoietic stem cells (HSCs) to lineage-restricted 
progenitors and to terminally differentiated red 
blood cells. The first wave of erythropoiesis, 
designated primitive erythropoiesis, is transient 
and begins around embryonic day (E) 7.5 in 
the  mouse  extraembryonic  yolk  sac  and/or 
aorta-gonad-mesonephros  (Palis  et  al.,  1999; 
Baumann and Dragon, 2005). Primitive erythro-
cytes (EryPs) represent the predominant blood 
cells in circulation until E12, when a second wave 
of erythroblasts generated in the fetal liver gives 
rise to definitive adult-type erythrocytes.
Erythropoiesis is critically dependent on the 
activity of the zinc finger transcription factor 
Gata-1 which is required for the expression of 
erythroid-specific  genes  (Welch  et  al.,  2004). 
Gata-1 binds to several different cofactors, in-
cluding Fog, Runx1, PU.1 EKLF, Lmo2, and 
SP1, and can function as both a transcriptional 
activator and a transcriptional repressor (Wadman 
et al., 1997; Johnson et al., 2007; Kim and 
Bresnick, 2007; Tripic et al., 2009). Multi-
subunit complexes containing Gata-1 in addi-
tion to the basic helix-loop-helix transcription 
factors Scl/Tal1 and E2A and the nuclear adapters 
Lmo2 and Lim domain binding protein 1 (Ldb1) 
have also been described in erythroid cell lines 
(Wadman et al., 1997). These multimeric com-
plexes bind to important regulatory sites at ery-
throid genes, and at the -globin locus, Ldb1 
facilitates long-range promoter–enhancer inter-
actions that are necessary for transcription (Xu 
et al., 2003; Song et al., 2007). Together, these 
results suggest that Ldb1 complexes may repre-
sent an important instrument for activating 
erythroid-specific gene transcription during de-
velopment. Supporting this idea, Lmo2, Gata-1, 
and Scl are each essential for erythropoiesis sug-
gesting that these proteins function cooperatively 
(Pevny et al., 1991; Warren et al., 1994; Robb 
et al., 1995, 1996; Shivdasani et al., 1995; Porcher 
et al., 1996; Schlaeger et al., 2005).
In this study, we examined the role of Ldb1 
in erythroid development by evaluating the im-
pact of ldb1 deletion on erythropoiesis using both 
conventional and conditional ldb1-deficient mice. 
Our results reveal an essential and continuous 
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During erythrocyte development, the nuclear cofactor Lim domain binding protein 1 (Ldb1) 
functions as a core subunit of multiprotein DNA binding complexes that include the tran-
scription factors Scl and Gata-1 and the Lim-only adapter Lmo2. Scl, Gata-1, and Lmo2 
are each required for erythropoiesis, suggesting that Ldb1-nucleated transcription com-
plexes regulate key steps during erythropoiesis. We documented a requirement for Ldb1 in 
erythropoiesis in mice. Analysis of ldb1/ embryos revealed a critical requirement for Ldb1 
during primitive erythropoiesis, and conditional inactivation of ldb1 at later stages of 
gestation and in adult mice demonstrated that Ldb1 is continuously required for both 
definitive erythropoiesis and megakaryopoiesis. Down-regulation of Ldb1 in erythroblasts 
inhibited the expression of multiple erythroid-specific and prosurvival genes. These results 
represent the first unequivocal demonstration of a role for Ldb1 in erythropoiesis in vivo 
and establish a critical function for Ldb1-nucleated complexes in regulating the erythroid/
megakaryocyte transcriptional program.
This article is distributed under the terms of an Attribution–Noncommercial–
Share Alike–No Mirror Sites license for the first six months after the publica-
tion date (see http://www.rupress.org/terms). After six months it is available 
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nonerythroid colonies that were apparent by day 6 of culture, 
ldb1/ yolk sac cells generated only nonerythroid colonies con-
sisting of myeloid blasts or mature macrophages that were 
role for Ldb1 in both primitive and definitive erythropoiesis as 
well as in adult megakaryopoiesis. Short hairpin (sh) RNA–
mediated knockdown of Ldb1 resulted in the down-regulation 
of multiple erythroid/megakaryocyte-specific genes as well as 
genes important for erythrocyte survival. These findings repre-
sent the first comprehensive demonstration of an in vivo role 
for Ldb1 in erythropoiesis and provide strong support for the 
idea that an Ldb1-nucleated multiprotein complex serves as a 
primary mechanism through which Gata-1 exerts its positive 
regulatory function in erythroid gene transcription.
RESULTS AND DISCUSSION
Ldb1 expression in the hematopoietic lineage
To examine Ldb1 expression in the hematopoietic lineage, 
adult bone marrow and fetal liver cells were stained intracel-
lularly with affinity-purified polyclonal Ldb1 antisera. FACS 
analysis revealed that Ldb1 levels are highest in lineagelo/Sca-1+ 
c-kit+ (LSK) cells (Fig. S1 A), which are known to contain 
hematopoietic  progenitors  including  HSCs  (Ikuta  and   
Weissman, 1992; Morrison et al., 1995). Indeed, in a separate 
study we found that Ldb1 is critical and continuously re-
quired for HSC maintenance (unpublished data). Slightly lower 
levels of Ldb1 were detected in lineage-committed pro-
genitor populations (common myeloid progenitors [CMPs],   
megakaryocyte-erythroid progenitors [MEPs], and granulocyte-
macrophage progenitors [GMPs]; Fig. S1 A). Interestingly, 
Ldb1 was also expressed at all stages of erythroid develop-
ment but was strongly down-regulated in mature myeloid 
(Gr1+) and lymphoid (B and T) cells (Fig. S1, B and C), suggest-
ing that Ldb1 may also have an important and specific func-
tion in erythropoiesis (Fig. S1 C).
Defective primitive erythropoiesis in the absence of Ldb1
It was reported previously that benzidine-positive cells are 
undetectable in ldb1/ yolk sacs, suggesting absent or defec-
tive primitive erythropoiesis (Mukhopadhyay et al., 2003).   
In agreement with this observation, in vitro–cultured embryoid 
bodies  derived  from  ldb1/  ES  cells  did  not  generate   
erythroid lineage cells, although myeloid lineage cells could be 
generated in the absence of Ldb1 (Fig. S2 A). Mesoderm/ 
hemangioblast marker genes and genes involved in Ldb1 
complex formation (lmo2, scl, gata2, and gata1) were expressed 
in day 5 ldb1/ embryoid bodies, but no expression of   
erythroid-specific genes was detectable at any time point ana-
lyzed (Fig. S2, B and C; and not depicted). Consistent with 
these data, there was no evidence of blood formation in E9 
ldb1/ embryos (Fig. 1 A, left). E9 ldb1/ yolk sac blood 
islands contained extremely low numbers of cells (Fig. 1 A, 
middle) that included rare myeloid blasts but no erythroblasts 
(Fig. 1 A, right). To evaluate the differentiation potential of 
progenitor cells in ldb1/ yolk sacs, single cell suspensions 
from E9 yolk sacs were cultured in vitro in hematopoietic 
differentiation medium. Cells from E9 ldb1/ yolk sacs   
generated 10-fold fewer total colonies than cells from con-
trol yolk sacs (Fig. 1 B and not depicted). In addition, al-
though control yolk sac cells gave rise to both erythroid and   
Figure 1.  ldb1 is required for primitive erythropoiesis. (A) E9.0 em-
bryos were photographed, paraffin embedded, and sectioned for H&E 
staining. Left, E9.0 ldb1+/+ and ldb1/ embryos from an ldb1+/ × ldb1+/ 
mating showing yolk sacs and blood vessels. Bars, 500 µm. Center, H&E 
staining of E9.0 embryos showing yolk sac blood islands. Arrows desig-
nate hematopoietic cells in yolk sac blood islands. Bars, 50 µm. Original 
magnification, 400×. Right, Giemsa staining of cytospins prepared from 
E9.0 yolk sac. Bars, 50 µm. Original magnification, 400×. Data are repre-
sentative of 3 ldb1/ embryos and 11 littermate controls. Controls  
consisted of ldb1+/+ and ldb1+/ embryos, which were phenotypically  
indistinguishable (not depicted). (B) Single cell suspensions from yolk sacs 
were prepared for in vitro methylcellulose culture. Erythroid (E) and non-
erythroid (non-E) CFCs in E9.0 ldb1/, ldb1+/, and ldb1+/+ yolk sacs. 
Colonies were counted on days 6 and 14 after the initiation of the in vitro 
culture. One representative of two experiments is shown. Values are ex-
pressed as means ± SD. (C) Giemsa staining of cytospins prepared from 
day 14 methylcellulose cultures derived from E9.0 ldb1+/+ or ldb1/ YS. 
Bars, 50 µm. Original magnification 400x. Images are representative of 
two experiments.JEM VOL. 207, November 22, 2010  2545
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GMP fetal liver LK cells was only slightly reduced in E12.5 
Tie2Cre ldb1fl/ mice, pointing to an early erythroid-specific 
defect (Fig. 2, B and C). Immature CD71hiTer119low–med pro-
erythroblasts and total Ter119+ cells were also strongly reduced 
in Tie2Cre ldb1fl/ embryos (Fig. 2, B and C).
To evaluate the developmental potential of E12.5 Tie2Cre 
ldb1fl/ fetal liver cells, we next performed in vitro methylcel-
lulose progenitor assays. After 8 d of culture, colonies were 
identified by visual inspection and enumerated. The number 
of erythroid colonies originating from Tie2Cre Ldb1fl/ fetal 
liver cells was strongly reduced relative to controls (Fig. 2,   
D and E). In addition, erythroid colonies from Tie2Cre ldb1fl/ 
mice  were  derived  almost  exclusively  from  EryP–colony 
forming cells (CFCs; Fig. 2 E). In contrast, most erythroid 
colonies from control fetal livers were derived from definitive 
burst  forming  unit–erythroid  (BFU-E)  progenitors  (Fig.  2,   
D and E; and not depicted). The near absence of definitive 
BFU-E colonies in Tie2Cre Ldb1fl/ fetal liver cultures is 
consistent with the reduced number of fetal liver erythroid 
progenitors (MEPs; Fig. 2, B and C). In contrast, the number 
of nonerythroid CFU-macrophage (M) and CFU-GM pro-
genitors were not significantly reduced in Tie2Cre ldb1fl/ 
fetal livers, identifying a selective requirement for ldb1 in 
erythroid development (Fig. 2, D and E).
Ldb1 is continuously required for adult erythropoiesis  
and megakaryopoiesis
To determine if Ldb1 is also required for adult erythropoiesis, 
we generated Mx1Cre ldb1fl/fl mice so that ldb1 deletion could 
be induced by injection of polyinosinic-polycytidylic acid (pI:
pC; Kühn et al., 1995). As shown in Fig. 3 A, most Mx1Cre 
ldb1fl/fl mice, but not control ldb1fl/fl mice, died within 20 d of 
pI:pC  injection.  As  reported  previously,  injection  of  pI:pC 
causes a transient anemia (Hall et al., 2003), and this was ob-
served in both control and Mx1Cre Ldb1fl/fl mice (Fig. 3 B). 
However, although the hematocrit normalized 14 d after   
pI:pC injection in control mice, the hematocrit continued to 
decline in Mx1Cre ldb1fl/fl mice (Fig. 3 B). The total num-
ber of bone marrow cells was also dramatically decreased in 
Mx1Cre ldb1fl/fl  mice  after  pI:pC-mediated  Ldb1  deletion 
(unpublished data). Similar to Tie2Cre ldb1fl/ mice, Linlo/ 
Sca1c-kithiCD34loFcRlo MEP populations, as well as CD71+
Ter119+erythroblasts, were significantly reduced in pI:pC-
treated Mx1Cre ldb1fl/fl mice (Fig. 3 C and Fig. S4 A). BFU-E 
and mixed (erythroid/myeloid) colonies were virtually ab-
sent in day 8 methylcellulose cultures of bone marrow cells 
from pI:pC-treated Mx1Cre Ldb1fl/fl mice (Fig. S4, B and C). 
Similar to the results obtained with Tie2Cre ldb1fl/ fetal 
liver  cells, granulocyte/macrophage colony formation was 
much less affected by inactivation of ldb1 in adult bone mar-
row cells (Fig. S4 C).
FACS  analysis  of  the  few  CD71+Ter119+erythroblasts 
present in Mx1Cre Ldb1fl/fl mice after pI:pC-induced deletion 
of ldb1 revealed an increase in the percentage of apoptotic (an-
nexin V+) cells as well as a reduced percentage of cycling cells, 
indicating a requirement for Ldb1 in cell survival (Fig. 3 C and 
apparent only after 10–14 d of culture (Fig. 1, B and C and not 
depicted). Together, these results demonstrate that hemato-
poietic specification is impaired and primitive erythropoiesis 
is abrogated in the absence of ldb1.
Ldb1 is required for definitive fetal erythropoiesis
To examine the role of Ldb1 in definitive erythropoiesis, we 
used a conditional deletion allele of ldb1 (ldb1fl) generated in 
ES  cells  by  homologous  recombination  (Suleiman  et  al., 
2007). Although ldb1/ mice die between E9 and E10, 
Ldb1fl/fl mice were viable and fertile and exhibited no hema-
topoietic defects (unpublished data). Cre-recombinase–mediated 
deletion of the ldb1fl alleles in oocytes recapitulated the early 
embryonic lethality observed in ldb1/ mice (unpublished 
data). Because our results indicated that Ldb1 was required 
for normal hematopoietic specification and primitive eryth-
ropoiesis, we generated mice in which conditional deletion 
of ldb1 was mediated by the tyrosine kinase with immuno-
globulin and epidermal growth factor homology domains 2 
(Tie2) Cre transgene (Kisanuki et al., 2001). In a previous study, 
it was shown that HSCs are generated in normal numbers 
and primitive erythropoiesis is partially rescued in Tie2Cre 
sclfl/fl embryos but that Tie2Cre-mediated gene deletion   
occurs in fetal liver hematopoietic progenitor cells that give 
rise to definitive erythrocytes (Schlaeger et al., 2005).
To increase the probability that ldb1 would be completely 
deleted after Cre expression, one Ldb1 allele was deleted in 
the germline to generate ldb1+/ mice. Tie2Cre ldb1+/ mice 
were then crossed with ldb1fl/fl mice to generate Tie2Cre 
ldb1fl/ embryos. Tie2Cre-mediated deletion of the ldbfl allele 
in fetal liver cells was confirmed by PCR of genomic DNA 
(Fig. S3 C). Tie2Cre ldb1fl/ embryos developed normally 
through E12. However, by E12.5, all Tie2Cre ldb1fl/ em-
bryos exhibited widespread hemorrhage and edema (Fig. S3 A). 
Fetal liver size and cellularity were markedly decreased in 
E11.5–14.5 Tie2Cre ldb1fl/ mice (Fig. S3, A and B) and no 
embryos survived beyond E14.5.
EryPs were detected in the blood of all E12.5 Tie2Cre 
ldb1fl/ embryos; however, a maturation defect was apparent 
from the high percentage of mitotic and basophilic cells and 
the high frequency of immature erythroid blasts (Fig. 2 A). 
This phenotype was strikingly similar to that observed in 
E12.5 Tie2Cre sclfl/fl mice (Schlaeger et al., 2005). The re-
duced cellularity in Tie2Cre ldb1fl/ fetal livers was due pri-
marily to low numbers of erythroid (Ter119+) cells (Fig. 2 B) 
and was most obvious on E13.0 and thereafter, when the de-
finitive erythroid pool was rapidly expanding in control em-
bryos but not in Tie2Cre Ldb1fl/ embryos (Fig. 2 C and Fig. 
S3 B). Importantly, although the total number of fetal liver 
cells was decreased in E12.5 Tie2Cre ldb1fl/ mice, the num-
ber of LSKs was normal at this time point indicating that the 
erythropoietic defects were not secondary to HSC depletion 
(Fig. 2 B). Analysis of downstream populations revealed a re-
duction in LinSca1c-kit+ (LK) fetal liver cells in Tie2Cre 
ldb1fl/ mice, reflecting a marked decrease in the number of 
MEP (Fig. 2, B and C). In contrast, the number of CMP and 2546 Ldb1 is essential for erythropoiesis | Li et al.
Figure 2.  ldb1 is required for definitive fetal erythropoiesis. (A) Giemsa-stained peripheral blood from E12.5 Tie2Cre ldb+/fl and Tie2Cre ldbfl/ embryos. Bars, 
50 µm. Original magnification, 400×. One representative of three experiments is shown. (B) Number of total fetal liver cells, LSK cells, LK cells, CMPs + GMPs, MEPs, 
and Ter119+ cells in E12.5 Ldb1fl/ Tie2Cre and control embryos (controls consisted of littermate ldb+/fl ± Tie2Cre and ldbfl/ embryos). NS, not significant; **, P < 0.01. 
MEP, CMP, and GMP populations were designated as shown in C. Ter119+ cell counts were obtained from 39 control embryos and 9 Tie2Cre ldbfl/ embryos. LSK, LK, 
CMP+GMP, and MEP cell counts were obtained from 32 control embryos and 12 Tie2Cre ldbfl/ embryos. Values are expressed as means ± SD. (C) Linlo/Sca1 
c-kit+FcRlo/CD34lo/ MEPs (left), total (Ter119+) erythroid cells (center), and CD71hiTer119lo proerythroblasts (right) in E12.5 Tie2Cre ldbfl/ and Tie2Cre ldb+/fl mice. 
Numbers are the percentage of cells in the indicated gate. (D) Numbers of erythroid (E), non-erythroid (non-E), and total colonies in day 8 methylcellulose cultures 
from E12.5 control and Tie2Cre ldbfl/ fetal livers. NS, not significant; *, P < 0.05; **, P < 0.01. One representative of three experiments is shown. Values are expressed 
as means ± SD. (E) Representative primitive erythroid (EryP), definitive erythroid (BFU-E), and myeloid (CFU-GM) colonies from Tie2Cre ldb+/fl and Tie2Cre ldbfl/ fetal 
livers at day 8 of culture. Bars, 200 µm. Original magnification, 50×. Images are representative of duplicate cultures from three litters.JEM VOL. 207, November 22, 2010  2547
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the peripheral blood of Mx1Cre ldb1fl/fl mice were markedly 
reduced relative to control ldb1fl/fl mice 8 d after pI:pC injec-
tion (Fig. 4 B).
Ldb1 is required for the expression of erythroid, 
megakaryocyte, and prosurvival genes
To evaluate the impact of Ldb1 down-regulation on the   
expression of erythroid- and megakaryocytic-specific genes, 
Fig. S4 A). To determine if Ldb1 is also important for mega-
karyocyte survival, sternal sections were obtained from pI:pC-
treated Mx1Cre ldb1fl/fl and control ldb1fl/fl mice and stained 
with hematoxylin and eosin (H&E). Strikingly, as early as 8 d 
after pI:pC injection, no megakaryocytes were detectable in 
sternum sections from pI:pC-treated Mx1Cre ldb1fl/fl mice, 
pointing to a critical role for Ldb1 in megakaryocyte survival 
(Fig. 3 D). In agreement with this finding, platelet counts in 
Figure 3.  Ldb1 is continuously required for erythropoiesis and megakaryopoiesis in adults. (A) Survival plot of adult MxCre ldb1fl/fl mice (n = 8) 
and control ldb1fl/fl mice (n = 6) after repeated pI:pC injection (arrows). (B) Hematocrits of MxCre ldb1fl/fl and control ldb1fl/fl mice after injection of pI:pC 
on days 1, 3, and 5. **, P < 0.01. Values are expressed as means ± SD. (C) Linlo/Sca1c-kit+FcRlo/CD34lo/ (MEP), CD71hiTer119lo proerythroblasts, and 
Ter119+CD71+ erythroblasts in BM of indicated mice after pI:pC injection. Numbers are the percentage of cells in the indicated gate. Histograms show the 
percentage of cycling (DAPIint–hi) and apoptotic (annexin V+) Ter119+CD71+ erythroblasts. (D) H&E-stained sternum sections from pI:pC-injected MxCre 
ldb1fl/fl and ldb1fl/fl mice. Arrows indicate megakaryocytes. Bars, 50 µm. (E) Peripheral blood platelet counts on days 4 and 8 after initial pI:pC injection.  
**, P < 0.01. Values are expressed as means ± SD. In C and D, mice were injected with pI:pC on days 1, 3, and 5 and sacrificed on day 8. In B–E, data shown 
are from four MxCre ldb1fl/fl mice and six littermate controls. Controls included ldb1fl/fl mice and ldb1fl+ mice ± MxCre.2548 Ldb1 is essential for erythropoiesis | Li et al.
knockdown of ldb1 strongly inhibited the induced expression 
of several erythroid genes including - and -globin, epb4.2, 
slc41, and alas2 (Fig. 4 A). In addition, expression of the 
megakaryocyte-specific transcript itga2b was also markedly 
decreased (Fig. 4 A). These results confirm and extend previ-
ous studies supporting a critical requirement for Ldb1 in ery-
throid gene expression (Xu et al., 2003; Anguita et al., 2004; 
Lahlil et al., 2004; Song et al., 2007). The dramatic increase in 
apoptotic erythroblasts after in vivo deletion of ldb1 (Fig. 3 C) 
also prompted us to examine the effect of ldb1 knockdown 
on the expression of erythroid prosurvival factors. As shown 
in Fig. 4 B, expression of three prosurvival genes, epor, bcl-xl, 
and sox6, was also significantly decreased in ldb1 shRNA 
MEL cells, especially at later time points in cell culture when 
these genes were highly induced in control cells (Fig. 4 B). These 
results indicate that Ldb1 protein complexes regulate the expres-
sion of prosurvival as well as erythroid- and megakaryocyte- 
specific genes.
In the present study, we relate data demonstrating a criti-
cal, continuous, and specific role for Ldb1 in both erythro-
poiesis and megakaryopoiesis. These results are consistent 
with the high expression of Ldb1 in erythroid progenitors 
(Fig. S1) and with the observation that deletion of ldb1 leads 
to a severe developmental block at the common megakaryo-
cyte/erythroid progenitor stage (Fig. 2 C and Fig. 3 C). De-
letion of ldb1 severely impacted the erythroid/megakaryocyte 
lineages but had little effect on the development of myeloid 
cells. Using B cell– or T cell–specific Cre transgenes, we also 
found no evidence of a requirement for ldb1 in lymphocyte 
development  (unpublished  data).  A  similar  nonmandatory 
role for lmo2 in T cell development was also demonstrated 
(McCormack et al., 2003).
Our results indicate that an important function of Ldb1 
during erythropoiesis is to induce the expression of lineage-
specific and prosurvival genes, presumably via its documented 
role as a key subunit of Ldb1/Lmo2/Scl/E2A/Gata-1 multi-
meric complexes (Fig. 4). Ldb1 nucleated complexes have 
been shown to regulate the expression of several erythroid 
genes including - and - globin, epb4.2, and gypA (Xu et al., 
2003; Anguita et al., 2004; Lahlil et al., 2004; Song et al., 
2007). In addition, genome-wide profiling studies have de-
tected Ldb1 at most Gata-1–bound DNA elements in ery-
throid cell lines, suggesting that Ldb1 complexes represent 
a major instrument for Gata-1–mediated gene activation 
(Tripic et al., 2009; Soler et al., 2010). In this paper, we   
provide evidence that down-regulation of Ldb1 severely im-
pairs the induced expression of multiple erythroid- and/or   
megakaryocyte-specific genes in erythroleukemia cells. Interest-
ingly, the expression of genes encoding other Ldb1 complex 
subunits, including lmo2, gata-1, and scl, was not as severely 
affected by down-regulation of ldb1, indicating that failure to 
assemble functional Ldb1 complexes, rather than reduced ex-
pression of Ldb1 complex subunits, is responsible for the re-
duction in erythroid gene expression (Fig. 4). In summary, 
these results establish an essential function for Ldb1 during 
erythrocyte  and  megakaryocyte  development  and  survival 
we analyzed gene expression in a Friend mouse erythroleukemia 
(MEL) cell line expressing a stable construct encoding ldb1 
shRNA (Song et al., 2007). Differentiation of the MEL cell 
line was stimulated by DMSO, which has been shown to 
induce  the  expression  of  erythroid-  and  megakaryocyte-
specific transcripts (Friend et al., 1973). As shown in Fig. 4 A, 
ldb1 transcripts were reduced by 20–50% in both uninduced 
and DMSO-induced Ldb1 shRNA MEL cells. Interestingly, 
Figure 4.  Ldb1 complexes regulate expression of erythroid, mega-
karyocytic, and prosurvival genes. Stable clones of MEL cells expressing 
ldb1 shRNA or control shRNA were treated with 1.5% DMSO to induce 
erythroid differentiation. Total RNA was isolated at the indicated times 
and gene expression was quantified by real-time RT-PCR with -actin as 
control. (A) Expression of genes encoding Ldb1 complex subunits and 
erythroid/megakaryocytic lineage proteins are shown. (B) Expression of 
prosurvival genes (bcl-xl, eopr, and sox6) in MEL cells expressing ldb1 
shRNA or control shRNA after induction with DMSO. Results shown are 
representative of two independent induction experiments. Values are 
expressed as means ± SD.JEM VOL. 207, November 22, 2010  2549
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RT-PCR and quantitative RT-PCR. The MEL cell line expressing ldb1 
shRNA has been described previously (Song et al., 2007). For gene expression 
studies, total cell RNA was isolated using PicoPure RNA isolation kit (Arcturus), 
and 100 ng of each RNA sample was reverse transcribed using SuperScript first-
strand synthesis system (Invitrogen) and assayed by RT-PCR. Transcript quanti-
fication was performed with a LightCycler 480 (Roche). Duplicates were run for 
each sample in a 96-well plate. -Actin was used as the endogenous reference 
gene. All quantitative RT-PCR reactions were run in three independent experi-
ments. The relative quantification method was used, with the ratio of the mRNA 
level for the gene of interest normalized to the level of -actin and the mean of 
control bone marrow samples as the calibrator value. The specificity of the prod-
ucts was confirmed based on melting curves and electrophoresis.
Genotyping  and  deletion  analysis  of  Tie2Cre  ldbfl/  mice  and   
Mx1Cre ldbfl/fl mice. PCR genotyping of Tie2Cre Ldbfl/ mice and Mx1Cre   
Ldbfl/fl mice was performed on tail DNA. Primers used for detection of the Cre 
transgene were 5-CGATGCAACGAGTGATGAGG-3 and 5-GACTT-
GCTGTCACTTGGTCGT-3. For Tie2Cre Ldbfl/ mice, a combination of 
the following three oligonucleotide primers were used to detect the wild-
type Ldb1, the Ldb1fl, and the Cre-mediated deleted (Ldb) alleles: Ldb1S 
5-CAGCAAACGGAGGAAACGGAAGATGTCAG-3, Ldb1AS 5-CTTA-
TGTGACCACAGCCATGCATGCATGTG-3, and Ldb1A 5-TCAGGC-
TGGCCTTTAAACCTAA-3. Ldb1S-Ldb1AS amplified a 320-bps wild-type 
allele fragment and 445-bps floxed allele fragment. Ldb1A-LdbAS amplified 
a 390-bps Ldb1 Cre-mediated recombination allele fragment. For Mx1Cre 
ldb1fl/fl mice, a combination of the following three oligonucleotide prim-
ers were used to detect the wild-type Ldb1, the Ldb1fl, and the Cre-mediated 
deleted  (ldb)  alleles:  Ldb1A  5-TCAGGCTGGCCTTTAAACCTAA-3, 
Ldb1B 5-TGGGACTACAAGGCTGAGAACA-3, and Ldb1C 5-TGGCT-
GAGCTTATGTGACCA-3. Ldb1B-Ldb1C amplified a 458-bp wild-type 
allele fragment and a 534-bp floxed allele fragment. Ldb1A-LdbC amplified a 
342-bp Ldb1 deleted allele fragment.
Conditional inactivation of Ldb1 in adult mice. To inactivate ldb1 in adult 
hematopoietic cells, 250 µl pI:pC (1 mg/ml; GE Healthcare) was injected intra-
peritoneally into each mouse on days 1, 3, and 5 (the day of the first injection 
was designated day 1). Mice were sacrificed on day 8 unless otherwise noted. 
Cells obtained from bone marrow or spleen were either analyzed directly or cul-
tured in methylcellulose to analyze their colony forming potential.
Online supplemental material. Fig. S1 shows Ldb1 expression in hema-
topoietic cells. Fig. S2 shows impaired erythroid developmental potential of 
ldb1/ ESCs. Fig. S3 shows defective erythropoiesis in Tie2Cre ldbfl/ em-
bryos. Fig. S4 shows that Ldb1 is continuously required for survival and ex-
pansion of erythroblasts in adults. Online supplemental material is available 
at http://www.jem.org/cgi/content/full/jem.20100504/DC1.
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